바이오소재 시장 보고서 : 유형별, 용도별, 지역별(2025-2033년)

The global biomaterials market size reached USD 126.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 289.7 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. Continuous advancements in the healthcare industry, along with the rising prevalence of cardiovascular diseases, are primarily propelling the market.

Biomaterials Market Analysis:

• Major Market Drivers: The increasing number of individuals with musculoskeletal conditions represents one of the primary drivers stimulating the market. Additionally, the rising adoption of these materials in dissolvable sutures and dressings, staples, and clips for wound closure is also acting as another significant growth-inducing factor.
• Key Market Trends: Several advancements in polymer synthesis, protein and peptide engineering, molecular self-assembly, and microfabrication technologies are among the emerging trends bolstering the market.
• Geographical Trends: North America exhibits a clear dominance across the market, owing to the expanding geriatric population who often need medical interventions. Moreover, the inflating number of research institutions and robust healthcare infrastructures is impelling the growth of the regional market.
• Competitive Landscape: As per the biomaterials market overview, some of the prominent companies include BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc, and Zimmer Biomet, among many others.
• Challenges and Opportunities: Stringent regulatory frameworks and extensive preclinical testing are hampering the market. However, the introduction of more predictive in-vivo and in-vitro models to assess biocompatibility before clinical use is expected to augment the market over the forecasted period.

Biomaterials Market Trends:

Development of 3D Printing Technologies

The introduction of novel innovations, including 3D printing technologies, is improving the ways in which medical implants and devices are designed and manufactured. Moreover, they enable the production of patient-specific and complex shapes that are difficult or impossible to achieve with traditional methods. Consequently, these technologies find extensive applications in fields, such as dentistry, orthopedics, prosthetics, etc., where anatomical precision is crucial. This, in turn, is one of the lucrative biomaterials market recent opportunities. For example, in February 2024, Nanavati Max Super Specialty Hospital launched a medical 3D printing laboratory in Mumbai to facilitate high-precision surgeries. This pioneering facility is closely integrated with oncology to offer state-of-the-art precision surgeries that are required to be performed accurately and carefully in reconstructive orthopedic, oncologic, and specialized dentistry surgeries. Additionally, the widespread integration of 3D printing technology in biomaterials for creating customized and complex medical devices and implants tailored to individual patients' anatomies is further gaining extensive traction across the globe. For instance, in October 2023, a study was published that assisted the occupational therapists at the Haukeland University Hospital in Bergen to develop personalized hand orthoses by using 3D printing and scanning technologies, which can reduce pain, minimize deterioration, enhance patient compliance, etc. Apart from this, 3D printing allows for the incorporation of gradients of materials with varying mechanical properties, which is also positively influencing the market. For example, in October 2023, Evonik launched implant-grade filaments and carbon-fiber-reinforced PEEK for numerous medical applications. Furthermore, these technologies assist in the treatment of chronic diseases, which is projected to fuel the overall biomaterials market outlook in the coming years. For example, in July 2023, through joint research with the Korea Research Institute of Bioscience and Biotechnology, the Korea Institute of Machinery and Materials, and the institute under the jurisdiction of the Ministry of Science and ICT launched the world's first 3D bioprinting technology that enhances the function of natural killer (NK) immune cells.

Innovations in Tissue Engineering

Tissue engineering plays an important role in biomaterials research. It is gaining immense popularity for developing biological substitutes to maintain, restore, or improve tissue function. For example, in June 2023, OrganaBio announced the introduction of NeoPAC placenta and umbilical cord tissues that are specifically designed to accelerate the progress of regenerative medicine and cell therapy. Moreover, by providing both Research Use Only (RUO) and clinical-grade tissues, OrganaBio encourages researchers to tap into the potential of birth tissues, thereby enabling the development of innovative therapies to address numerous medical conditions. Apart from this, the rising demand for novel scaffolds that are materials engineered to cause desirable cellular interactions to facilitate the formation of new tissues is also elevating the market. For instance, in June 2023, 3DBioFibR, one of the leading innovators in tissue engineering, released two new collagen fiber products, namely CollaFibR 3D and μCollaFibR scaffold. These variants offer significant benefits for tissue culture and tissue engineering applications. Additionally, the elevating investments in R&D activities and research facilities by various organizations to enable the engineering of more structurally and functionally accurate tissues are contributing to the biomaterials market revenue. For example, in January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Center for Biomedical Engineering Technology Acceleration (BETA Center), a new intramural research program to accelerate the validation, development, and dissemination of cutting-edge technologies. The center focuses on several areas, such as biosensing, engineered and synthetic biology, biomedical imaging, nanomaterials and biomaterials, etc.

Growing Applications in Wound Dressings

The rising adoption of biomaterials in advanced wound dressings, as they help in improving the healing process and outcomes for numerous types of wounds, including acute and chronic injuries, is acting as a significant growth-inducing factor. Besides this, key players are developing sustainable materials for wound care. For example, in March 2024, a team of scientists at the Institute of Advanced Study in Science and Technology (IASST), under the Department of Science and Technology, introduced an eco-friendly wound dressing material made using banana fibers. Moreover, all the materials utilized in creating this innovative dressing material are locally available and natural, making the manufacturing process cost-effective, simple, and non-toxic. Apart from this, the increasing inclination towards bio-material-based wound dressings is elevating the biomaterials market prices. They can be produced from various materials, including foams, hydrogels, films, etc., that are often imbued with bioactive substances like antimicrobial agents to reduce infection and promote tissue regeneration. For instance, in May 2022, Amferia AB, a Swedish medical device startup, was granted a foundational patent by the U.S. Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. In line with this, in June 2023, according to the findings published in the Journal of Biomaterials Advances, a team of researchers from Queen's University of Belfast designed a 3D printed bandage, also called a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs).

Global Biomaterials Market Segmentation:

Breakup by Type:

• Natural Biomaterial
• Metallic Biomaterial
• Ceramic Biomaterial
• Polymeric Biomaterial

Currently, metallic biomaterial accounts for the largest market share

The growth in this segmentation is driven due to exceptional strength, optimal durability, and enhanced biocompatibility exhibited by metallic biomaterials. Consequently, they find extensive load-bearing applications, including dental implants, orthopedic implants, cardiovascular devices, etc. For instance, in April 2024, Boston Micro Fabrication (BMF) announced the U.S. Food and Drug Administration (FDA) clearance for its innovative UltraThineer material. Moreover, several metals, such as stainless steel, titanium, cobalt-chromium alloys, etc., are widely used, owing to their superior mechanical properties that ensure longevity and resilience under the stress of bodily movements. For example, in January 2022, according to the journal Colloids and Surfaces A, researchers efficiently modified a TC26 alloy with nanoporous TiO2 to enhance the osseointegration and bioactivity of artificial implants. In addition to this, in June 2023, Technopolis Moscow SEZ announced the production of titanium implants. As a result, the increasing product applications will continue to drive the metallic biomaterials market demand in the coming years.

Breakup by Application:

• Neurology
• Cardiology
• Orthopedics
• Wound Care
• Dental
• Plastic Surgery
• Others

Durable ceramic, metallic, and polymer-based materials are essential for joint replacements and bone repair. Moreover, they are adopted in the manufacturing of reconstructive devices that require high compatibility and strength with oral tissues. Apart from this, key areas, including neurology and cardiology, require biomaterials for neural implants, brain-machine interfaces, stents, pacemakers, etc. For instance, in February 2022, Researchers at the Lundquist Institute for Biomedical Innovation, Penn State, and the University of California Los Angeles developed novel biomaterials to promote new blood vessels and target post-stroke immune responses. According to the biomaterials market statistics, the other category encompasses additional applications like drug delivery systems and ophthalmology, where biomaterials offer tailored solutions for implants and controlled medication release, respectively.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest biomaterials market share.

The favorable regulatory environment in North America, particularly the role of the U.S. Food and Drug Administration (FDA), which supports the rapid approval and development of new biomaterials and medical devices, is fueling the regional market. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which is based on a different biomaterial Zfuze, a combination of titanium and poly-ether-ether-ketone. Additionally, in October 2023, Dimension Inx, one of the biomaterials platform companies, announced the FDA approval of CMFlex, the first 3D-printed regenerative bone graft product. Moreover, the growing number of ambulatory surgical centers (ASCs) that perform spinal surgeries is acting as another significant growth-inducing factor. For instance, in February 2023, according to Becker's Healthcare data showcased that more than 183 ASCs in the United States perform minimally invasive spine surgery (MISS). Apart from this, the inflating popularity of cosmetic surgeries is further stimulating the regional market. In addition, the launch of initiatives undertaken by several public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, which provide assistance pertaining to biomaterials usage, is expected to fuel the market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major biomaterials market companies have also been provided. Some of the key players in the market include:

• BASF SE
• Berkeley Advanced Biomaterials
• Carpenter Technology Corporation
• Collagen Matrix Inc.
• CoorsTek Inc.
• Corbion N.V.
• Dentsply Sirona
• Evonik Industries AG
• Johnson & Johnson
• Koninklijke DSM N.V.
• Medtronic plc
• Stryker Corporation
• Victrex plc
• Zimmer Biomet

Key Questions Answered in This Report

• 1.What was the size of the global biomaterials market in 2024?
• 2.What is the expected growth rate of the global biomaterials market during 2025-2033?
• 3.What are the key factors driving the global biomaterials market?
• 4.What has been the impact of COVID-19 on the global biomaterials market?
• 5.What is the breakup of the global biomaterials market based on type?
• 6.What are the key regions in the global biomaterials market?
• 7.Who are the key players/companies in the global biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Biomaterials Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Natural Biomaterial
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Metallic Biomaterial
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Ceramic Biomaterial
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Polymeric Biomaterial
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Application

• 7.1 Neurology
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cardiology
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Orthopedics
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Wound Care
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Dental
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Plastic Surgery
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Others
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 BASF SE
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Berkeley Advanced Biomaterials
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Carpenter Technology Corporation
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Collagen Matrix Inc.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 CoorsTek Inc.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Corbion N.V.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Dentsply Sirona
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Evonik Industries AG
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Johnson & Johnson
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Koninklijke DSM N.V.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis
  • 13.3.11 Medtronic plc
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
    • 13.3.11.4 SWOT Analysis
  • 13.3.12 Stryker Corporation
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
    • 13.3.12.3 Financials
    • 13.3.12.4 SWOT Analysis
  • 13.3.13 Victrex plc
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio
    • 13.3.13.3 Financials
  • 13.3.14 Zimmer Biomet
    • 13.3.14.1 Company Overview
    • 13.3.14.2 Product Portfolio
    • 13.3.14.3 Financials
    • 13.3.14.4 SWOT Analysis